overcharging
-
Mylan Ripped Off The US Government, Ironically By Misclassifying EpiPens As A Generic Drug
The US government spent over $US1.3 billion ($1.7 billion) on EpiPens from 2011 to 2015. But Mylan, the makers of EpiPen, has been overcharging the government for the life-saving allergy medication by misclassifying it as a generic, rather than a name brand drug. If you don’t know whether to laugh or cry at this point,…